B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cromakalim

300 PubMed studies analyzed · 3 RCTs · Evidence Score: 44.3

Research Domains

Cromakalim has been studied across 16 research domains including ❤️ Cardiovascular, ⚡ Energy & Fatigue, 🦴 Bone & Joint, 🧠 Focus & Attention, 🔥 Metabolic. The primary research focus is ❤️ Cardiovascular with 24% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cromakalim is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.